RCH logo

Microbiology

RCH Antimicrobial Sensitivity Data 2013

  • Organism Ampicillin Augmentin Cephalexin Trimethoprim Cotrimoxazole Gentamicin
    E. coli(27) 14/27 (52%) 22/27 (81%) 0/11(0%) 18/25 (72%) 19/27 (70%) 27/27 (100%)
    Enterobacterspp (16) 10/16 (63%) 13/16 (81%)
    Klebsiellaspp (26) 21/25 (84%) 10/13 (77%) 18/24 (75%) 19/25 (76%) 23/25 (92%)
    Pseudomonas aeruginosa(13) 13/13 (100%)
    Organism Ciprofloxacin Tobramycin Amikacin Ceftriaxone Tazocin Timentin Meropenem
    E. coli(27) 26/27 (96%) 27/27 (100%) 27/27 (100%) 26/27 (96%) 23/27 (85%) 27/27 (100%)
    Enterobacterspp (16) 15/16 (94%) 13/16 (81%) 16/16 (100%) 12/16 (75%) 12/16 (75%) 13/16 (81%) 14/16 (88%)
    Klebsiellaspp (26) 25/25 (100%) 22/25 (88%) 25/25 (100%) 24/25 (96%) 23/25 (92%) 21/25 (84%) 25/25 (100%)
    Pseudomonas aeruginosa(13) 12/13 (92%) 13/13 (100%) 13/13 (100%) 8/13 (62%) 4/13 (31%) 11/13 (85%)

     

    Key:

    Green: > 80% susceptible
    Red: 30% susceptible
    Orange: variable susceptibility (30-80%)

    These susceptibillity results for 2013 include all ist blood culture isolates. Repeat isolation of the same organism within 2 weeks

    from initial collection are excluded from analysis